Respiratory tract infection: Epidemiology and surveillance

Journal of Chemotherapy

Volumn 9, Issue SUPPL. 3, 1997, Pages 10-17

  Jacobs, M R ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Community acquired respiratory tract infection; Epidemiology; Resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFUROXIME AXETIL; CLARITHROMYCIN; ERYTHROMYCIN; LORACARBEF; MACROLIDE;

ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; COMMUNITY; CONFERENCE PAPER; DISEASE SEVERITY; DRUG CHOICE; HAEMOPHILUS INFLUENZAE; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MINIMUM INHIBITORY CONCENTRATION; PREVALENCE; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; UPPER RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; NEISSERIACEAE INFECTIONS; PNEUMOCOCCAL INFECTIONS; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0030741266     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (25)

1. Paradise JL. Treatment guidelines for otitis media: the need for breadth and flexibility. Pediatr Infect Dis J 1995; 14: 429-435.
2. Jacobs MR. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in otitis media. Pediatr Infect Dis J 1996; 15: 940-943.
3. Gilbert K, Fine MJ Assessing progress and predicting patient outcome in community-acquired pneumonia. Semin Respir Infect 1994; 9: 140-152.
4. Jabes D, Nachman S, Tomasz A. Penicillin-binding protein families: Evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci. J Infect Dis 1989; 159: 16-25.
5. Jorgensen JH. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 1992; 14: 1119-1123.
6. Sutcliffe J, Grebe T, Tait-Kamradt A, Wondrack L. Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 1996; 40: 2562-2566.
7. Hakenbeck R, Ellerbrok H, Briese T, Handwerger S, Tomasz A. Penicillin-binding proteins of penicillin-susceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying the beta-lactam binding site. Antimicrob Agents Chemother 1986, 30: 553-558.
8. Jacobs MR, Appelbaum PC. Antibiotic-resistant pneumococci. Rev Med Microbiol 1995; 6: 77-93.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Villanova, PA: 1995; NCCLS, Sixth Information Supplement M100-S6, Vol 15 No 14, NCCLS.
10. Marton AM, Gulyas R, Munoz A, Tomasz A. Extremely high incidence of antibiotic resistance in clinical isolates of Streptococcus pneumoniae in Hungary. J Infect Dis 1991; 163: 542-548.
11. Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr Infect Dis J 1996; 22: 255-259.
12. Spangler S, Jacobs MR, Appelbaum P. Activities ot RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidonones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother 1996; 40: 481-484.
13. Nelson CT, Mason EO, Kaplan SL. Activity or oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994; 13: 585-589.
14. Grüneberg RN, Felmingham D and the Alexander Project Group. Results of the Alexander Project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagn Microbiol Infect Dis 1996; 25: 169-181.
15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA: 1993; NCCLS Approved Standard M7-A3.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Villanova, PA: 1994; NCCLS, Fifth Information Supplement M100-S5, Vol 15 No 16, NCCLS.
17. Doern GV. Trends in antimicrobial susceptibility of bacterial pathogens of the respiratory tract. Am J Med 1995; 99: 3S-7S.
18. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: An overview. Clin Infect Dis 1992; 15: 77-83.
19. Doern GV, Jorgensen JH, Thornsberry C, Preston DA. Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagn Microbiol Infect Dis 1986; 4: 95-107.
20. Doern GV, Jorgensen JH, Thornsberry C, et al. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother 1988; 2: 180-185.
21. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990; 34: 2075-2080.
22. Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993. Antimicrob Agents Chemother 1994; 38: 2419-2425.
23. Rittenhouse SF, Miller LA, Kaplan RL, Mosely GH, Poupard JA. A survey of beta-lactamase-producing Haemophilus influenzae. An evaluation of 5750 isolates. Diagn Microbiol Infect Dis 1995; 21: 223-225.
24. Jones RN, Jacobs MR, Washington JA, Pfaller MA. A 1994-95 survey of Haemophilus influenzae susceptibility to 10 orally administered agents: a 187 clinical laboratory center sample in the United States. Diagn Microbiol Infect Dis 1997; in press.
25. Jacobs MR, Bajaksouzian S. Microbiologie evaluation of contemporary Haemophilus influenzae isolates having elevated MICs to amoxycillin-clavulanic acid. Diagn Microbiol Infect Dis 1997; in press.